CASD1 and cancer: This opens new experimental avenues for the development of effective therapeutic strategies targeting CASD1 to regulate pathological changes in the 9-O-acetylation status and to combat drug-resistant cancer cells in ALL, whose survival crucially depend on 9-O-acetylation23.